Streetbeat News

Products Services

BWMN

Bowman Consulting Group has been contracted to provide engineering services for safety improvements on Roosevelt Boulevard in Philadelphia. This project could enhance Bowman's reputation and lead to further contracts.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:05 am

AXSM

Axsome Therapeutics announced that the FDA has acknowledged the resubmission of its New Drug Application for AXS-07, a treatment for acute migraine. The FDA has classified it as a Class 2 resubmission with a PDUFA action goal date set for January 31, 2025.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:04 am

CRM

FEPI

IGV

Salesforce (CRM) shares are slightly down despite a strong earnings report and a new acquisition of AI company Tenyx. The acquisition aims to enhance Salesforce's AI capabilities in customer service. Investors can also gain exposure through ETFs like IGV and FEPI.

Portfolio Pulse from Nabaparna Bhattacharya

September 04, 2024 | 11:02 am

GTLB

NVDA

PD

QQQ

SPY

ZS

US stock futures are down, with the VIX spiking 10% and Bitcoin sliding. Nvidia is down over 1% in premarket trading. Analysts suggest focusing on defensive stocks amid mixed economic data. GitLab surged 17% on earnings, while PagerDuty and Zscaler fell over 14%.

Portfolio Pulse from Shanthi Rexaline

September 04, 2024 | 11:01 am

MRK

Merck and EyeBio have launched a Phase 2b/3 trial for Restoret™ (MK-3000) to treat diabetic macular edema. This trial follows promising results from earlier studies, marking a significant step in developing new treatments for retinal diseases.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 10:45 am

RIVN

TSLA

Former Tesla executive Rohan Patel predicts a decade of upheaval in the auto industry, emphasizing the need for efficiency and innovation over protectionist measures. Tesla CEO Elon Musk questions Rivian's financial reliance on Volkswagen amidst the latter's potential factory closures in Germany due to competitive pressures.

Portfolio Pulse from Anan Ashraf

September 04, 2024 | 10:41 am

KARS

NIO

PGJ

NIO Inc. shares are trading higher in the premarket session, driven by the company's expansion of battery swap stations in China. NIO added 40 new stations in August, with 35 being the latest fourth-generation models. The company aims to expand its network to cover over 2,300 counties by the end of 2025. Investors can gain exposure to NIO through ETFs like KraneShares Electric Vehicles and Future Mobility Index ETF (KARS) and Invesco Golden Dragon China ETF (PGJ).

Portfolio Pulse from Nabaparna Bhattacharya

September 04, 2024 | 10:32 am

IMUX

Immunic has enrolled the first patient in a Phase 2 trial of Vidofludimus Calcium (IMU-838) for treating post-COVID syndrome. This trial is investigator-sponsored and marks a significant step in exploring treatments for long-term COVID-19 effects.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 10:32 am

MYGN

Myriad Genetics has decided to discontinue the second part of a study due to significant disparities between the GeneSight group and the control group, which was deemed not viable.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 10:20 am

SOPH

SOPHiA GENETICS has launched a new generation of its SOPHiA DDMTM platform, which is expected to enhance data-driven medicine capabilities. This development could potentially impact the company's market position and attract investor interest.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 10:09 am